MedPath

Comparison Of Metformin And Exercise On Insulin Resistance In Women With Polycystic Ovary Syndrome

Not yet recruiting
Conditions
Endocrine disorder, unspecified,
Registration Number
CTRI/2020/10/028473
Lead Sponsor
Post Graduate Institute Of Medical Education And Research
Brief Summary

This is a randomized control trial aimed to compare the effect of metformin and moderate intensity exercise on insulin resistance in patients with PCOS.

Women between 18-40 years of age who are overweight/obese shall be included for the study after considering the exclusion criteria.

At baseline,  anthropometry, body composition, hormonal profile and metabolic parameters would be recorded and hyperinsulinemic-euglycemic clamp would be done

Thereafter the participants would be randomised into metformin and the exercise group.

A 2 week run in period shall be given to the participants to acclimatise to the exercise program and  tolerance to metformin shall be assessed.

The patients shall be  followed at 0, 2 and 4 months.

Compliance to the intervention shall be ensured with telephonic calls.

At 4 months, metabolic. hormonal profile shall be repeated along with hyperinsulinemic-euglycemic clamp to assess the change in insulin resistance.

12 Healthy, age and BMI matched controls will be taken and a hyperinsulinemic euglycemic clamp would be performed at baseline for comparison.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Female
Target Recruitment
12
Inclusion Criteria

overweight/obese PCOS women based on Asian BMI classification.

Exclusion Criteria

Diabetes Mellitus Bleeding Disorders Hepatic or renal insufficiency Acute Infection Chronic Disorders Use of oral contraceptives/ hormone replacement therapy/insulin sensitizers within the past six weeks PREGNANCY H/O CAD/CVA/VTE SMOKING.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Effect on insulin resistance4 months
Secondary Outcome Measures
NameTimeMethod
Alterations In Body Mass Index, HOMA -IR, Luteinizing hormone, Follicle stimulating hormone,Testosterone4 Months

Trial Locations

Locations (1)

Post Graduate Institute Of Medical Education And Research, Chandigarh

🇮🇳

Chandigarh, CHANDIGARH, India

Post Graduate Institute Of Medical Education And Research, Chandigarh
🇮🇳Chandigarh, CHANDIGARH, India
Jasmeet Kaur Bhalla
Principal investigator
9876327236
jaskaurbhalla@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.